iifl-logo

SBI Healthcare Opportunities Fund Direct G

SBI Healthcare Opportunities Fund Direct G

Fund Name

SBI Mutual Fund

Scheme Name

SBI Healthcare Opportunities Fund Direct G

AMC

SBI Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

01-Jan-2013

Fund Manager

Tanmaya Desai

Net Assets (Rs. cr)

4026.55

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

SBI Healthcare Opportunities Fund Direct G - Nav Details

Nav Date

:  14-Aug-2025

NAV [Rs.]

:  495.5113

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

NIL.

Exit Load %

For exit within 1 year from th date of allotment - 1%. For exit after 1 years from the date of alltmen - NIL.

SBI Healthcare Opportunities Fund Direct G- NAV Chart

SBI Healthcare Opportunities Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-1.23
-1.05
3.65
6.49
11.51
27.64
21.27
18.08
Category Avg
2.11
0.72
6.29
8.28
7.09
24.37
19.45
16.85
Category Best
3.51
3.31
10.07
12.44
20.42
29.19
22.63
36.06
Category Worst
-1.25
-3.44
0.25
3.63
-7.9
19.83
14.56
-2.54

SBI Healthcare Opportunities Fund Direct G- Latest Dividends

No Records Found

SBI Healthcare Opportunities Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Anthem Bioscienc12,00,000

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology11.442700000460.80
EquityDivi's Lab.Pharmaceuticals & Biotechnology7.21440000290.20
EquityMax HealthcareHealthcare Services6.502100000261.66
EquityCiplaPharmaceuticals & Biotechnology4.631200000186.55
Foreign EquityLonza GroupPharmaceuticals & Biotechnology4.09270000164.88
EquityLupinPharmaceuticals & Biotechnology4.02840000162.04
EquityGland PharmaPharmaceuticals & Biotechnology3.59700000144.53
EquityMankind PharmaPharmaceuticals & Biotechnology3.57560000143.76
EquityAcutaas ChemicalPharmaceuticals & Biotechnology3.301000000132.74
EquityKrishna Institu.Healthcare Services3.261750000131.46
EquityFortis Health.Healthcare Services3.191500000128.61
EquityBioconPharmaceuticals & Biotechnology3.113200000125.24
EquityAbbott IndiaPharmaceuticals & Biotechnology3.0836000123.85
EquityLaurus LabsPharmaceuticals & Biotechnology3.041400000122.40
EquityAster DM Health.Healthcare Services3.002000000120.98
EquityTorrent Pharma.Pharmaceuticals & Biotechnology2.97320000119.74
EquityConcord BiotechPharmaceuticals & Biotechnology2.85649000114.69
EquityJupiter Life LinHealthcare Services2.84800000114.40
EquityPoly MedicureHealthcare Equipment & Supplies2.70560000108.51
EquityAether Industri.Chemicals & Petrochemicals2.671400000107.37
EquityAlkem LabPharmaceuticals & Biotechnology2.50200000100.62
EquityAnthem BiosciencPharmaceuticals & Biotechnology2.26120000091.09
EquityRainbow Child.Healthcare Services2.1256000085.36
EquityAurobindo PharmaPharmaceuticals & Biotechnology1.9870000079.78
EquityCohance LifePharmaceuticals & Biotechnology1.8675000074.88
EquityVijaya Diagnost.Healthcare Services1.6060000064.50
EquityPfizerPharmaceuticals & Biotechnology1.2910000051.94
EquityAkums DrugsPharmaceuticals & Biotechnology1.0380000041.54
EquityGufic BioSciencePharmaceuticals & Biotechnology0.99100000039.71
EquitySanofi ConsumerPharmaceuticals & Biotechnology0.917500036.81
Money Market Investments
T BillsTBILL-182D-/-0.073000002.95
Cash & Cash Equivalent
Reverse RepoTREPS-/-2.770111.53
Net CA & OthersNet CA & Others-/--0.440-18.69

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
SBI Mutual Fund
Incorporation Date:
07-Feb-1992
Total Assets Managed (Cr.):
11,45,315.39
Trustee/s:
Sandra Martyres, Bharati Rao, Smt. Manju Agarwal, SBI Mutual Fund Trustee C, Richard Mendonca, Mr. Dhruv Prakash
Chairman:
NA
CEO / MD:
Nand Kishore
CIO:
NA
President:
NA
Director/s:
Om Prakash Gahrotra, Dr. Prafulla Agnihotri, Mrs. Madhu Dubhashi
Compliance Officer/s:
NA
Investor Service Officer/s:
NA
Fund Manager/s:
Tanmaya Desai
Auditors:
Sudit K Parekh & Co, M/S Chandabhoy&Jassoobhoy

OTHER INFORMATION

Registered Office:
9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051.
Contact Nos:
022-61793000
Fax:
022-67425687
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.